Keywords: ابتکار کیفیت نتایج کلی بیماری کبد; AVF; arteriovenous fistula; KDOQI; Kidney Disease Outcomes Quality Initiative; PCB; paclitaxel-coated balloon; PTA; percutaneous transluminal angioplasty;
مقالات ISI ابتکار کیفیت نتایج کلی بیماری کبد (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ابتکار کیفیت نتایج کلی بیماری کبد; AVF; arteriovenous fistula; AVG; arteriovenous graft; CKD; chronic kidney disease; EJV; external jugular vein; GFR; glomerular filtration rate; IJV; internal jugular vein; IR; interventional radiology; K/DOQI; Kidney Disease Outcomes Quality Initiative; P
Keywords: ابتکار کیفیت نتایج کلی بیماری کبد; BMD; bone mineral density; BMI; body mass index; BMU; basic multicellular unit; CAV; cardiac allograft vasculopathy; CKD; chronic kidney disease; CS; corticosteroids; DXA; dual energy X-ray absorptiometry; FASL; FAS ligand; FRAX; Fracture Risk Assessment
Keywords: ابتکار کیفیت نتایج کلی بیماری کبد; AR; access recirculation; AVF; arteriovenous fistula; AVG; arteriovenous graft; DHIS; distal hypoperfusion ischemia syndrome; KDOQI; Kidney Disease Outcomes Quality Initiative; NKF; National Kidney Foundation; Qa; blood access flow rate;
Keywords: ابتکار کیفیت نتایج کلی بیماری کبد; AKI; acute kidney injury; AKIN; Acute Kidney Injury Network; CIN; contrast-induced nephropathy; CKD; chronic kidney disease; CT; computed tomographic; eGFR; estimated glomerular filtration rate; EMR; electronic medical record; KDOQI; Kidney Disease Outcom
Keywords: ابتکار کیفیت نتایج کلی بیماری کبد; K/DOQI; Kidney Disease Outcomes Quality Initiative;
Randomized Trial Comparing the Primary Patency following Cutting Versus High-Pressure Balloon Angioplasty for Treatment of de Novo Venous Stenoses in Hemodialysis Arteriovenous Fistulae
Keywords: ابتکار کیفیت نتایج کلی بیماری کبد; AV; arteriovenous; KDOQI; Kidney Disease Outcomes Quality Initiative; RBP; rated burst pressure; RCT; randomized controlled trial;
Improved glomerular filtration rate estimation using New equations combined with standardized cystatin C and creatinine in Chinese adult chronic kidney disease patients
Keywords: ابتکار کیفیت نتایج کلی بیماری کبد; eGFR; estimated glomerular filtration rate; CKD-EPI; Chronic Kidney Disease Epidemiology Collaboration; CKD; chronic kidney disease; MDRD; Modification of Diet in Renal Disease; Scr; serum creatinine; ScysC; serum cystatin C; CysC; cystatin C; DTPA; dieth
Desde las guÃas americanas KDOQI⢠2003 hasta las guÃas españolas 2011: desde el diagnóstico y evaluación hasta el tratamiento de las alteraciones del metabolismo mineral y óseo en la enfermedad renal crónica
Keywords: ابتکار کیفیت نتایج کلی بیماری کبد; Chronic kidney disease-mineral and bone disorder; Kidney disease outcomes quality initiative; Kidney disease improving global outcomes; GuÃas; Recomendaciones; GuÃas americanas; Enfermedad renal crónica; Hiperparatiroidismo secundario; Hormona paratiro
Diagnostic value of transferrin
Keywords: ابتکار کیفیت نتایج کلی بیماری کبد; AASLD; American Association for the Study of Liver Diseases; CHD; Coronary heart disease; CI; Confidence interval; CKD; Chronic kidney disease; DM; Diabetes mellitus; EASL; European Association for the Study of the Liver; ESA; Erythropoiesis-stimulating a
Salvage of Angioplasty Failures and Complications in Hemodialysis Arteriovenous Access Using the FLUENCY Plus Stent Graft: Technical and 180-Day Patency Results
Keywords: ابتکار کیفیت نتایج کلی بیماری کبد; AV; arteriovenous; AVF; autogenous arteriovenous fistula; AVG; prosthetic arteriovenous graft; K-DOQI; Kidney Disease Outcomes Quality Initiative; PIPP; postintervention primary patency; PISP; postintervention secondary patency; PTA; percutaneous translum
The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation provides a better definition of cardiovascular burden associated with CKD than the Modification of Diet in Renal Disease (MDRD) Study formula in subjects with type 2 diabetes
Keywords: ابتکار کیفیت نتایج کلی بیماری کبد; CKD; chronic kidney disease; ESRD; end-stage renal disease; CVD; cardiovascular disease; NKF; National Kidney Foundation; KDOQI; Kidney Disease Outcomes Quality Initiative; GFR; glomerular filtration rate; MDRD; Modification of Diet in Renal Disease; CKD-
Impact of Kidney Disease Outcomes Quality Initiative Guidelines on the Prevalence of Chronic Kidney Disease After Living Donor Nephrectomy
Keywords: ابتکار کیفیت نتایج کلی بیماری کبد; kidney failure, chronic; living donors; nephrectomy; BMI; body mass index; CKD; chronic kidney disease; eGFR; estimated glomerular filtration rate; ESRD; end stage renal disease; GFR; glomerular filtration rate; HALDN; hand assisted laparoscopic donor nep
Endpoints for Hemodialysis Access Procedures: Correlation between Fistulography and Intraaccess Blood Flow Measurements
Keywords: ابتکار کیفیت نتایج کلی بیماری کبد; ABF; access blood flow; CI; confidence interval; KDOQI; Kidney Disease Outcomes Quality Initiative; UCSD; University of California San Diego;
Outcomes of Thrombectomy Procedures Performed in Hemodialysis Grafts with Early Failure
Keywords: ابتکار کیفیت نتایج کلی بیماری کبد; CAQ; certificate or added qualification; CI; confidence interval; K/DOQI; Kidney Disease Outcomes Quality Initiative; PTA; percutaneous transluminal angioplasty; U30; graft < 30 days group; U60; graft 30-60 days group;
Clinical utility of calcimimetics targeting the extracellular calcium-sensing receptor (CaSR)
Keywords: ابتکار کیفیت نتایج کلی بیماری کبد; CaSR; calcium-sensing receptor; Cao2+; extracellular calcium concentration; PTH; parathyroid hormone; NKF; National Kidney Foundation; FDA; US Food and Drug Administration; CKD; chronic kidney disease; MGluR; metabotropic glutamate receptor; GABA; gamma a
Use of Erythropoiesis-Stimulating Agents in Patients With Anemia of Chronic Kidney Disease: Overcoming the Pharmacological and Pharmacoeconomic Limitations of Existing Therapies
Keywords: ابتکار کیفیت نتایج کلی بیماری کبد; CHOIR; Correction of Hemoglobin and Outcomes in Renal Insufficiency; CKD; chronic kidney disease; CREATE; Cardiovascular Risk Reduction by Early Anemia Treatment with Epoetin Beta; ESA; erythropoiesis-stimulating agent; FDA; Food and Drug Administration;